Background: Current guidelines recommend the use of fractional flow reserve (FFR) for guiding the decision for coronary revascularization. Recently, new parameters are being validated for intracoronary ischemia detection.There are few data on the intrinsic biological variability of these measurements. The objective of this study was to evaluate the reproducibility of the different methods of intracoronary diagnosis. Methods: We prospectively enrolled consecutive intermediate coronary lesions during a 6-month period. In all cases we systematically obtained measurements of the following parameters (in the same lesion using the same sequence): Pd/Pa, iFR, FFRic (after 80 mg intracoronary adenosine) and FFRiv (after intravenous adenosine at 140 mg/kg/min). At least two measurements of each parameter were obtained separated by a minimum interval of 3 minutes. The agreement between the measurements of each parameter was assessed using the intra-class correlation coefficient (ICC) and the Bland-Altman method. The variability of the four parameters was estimated using the variation coefficient (VC University of ROSTOCK, Rostock, Germany Background: Current guidelines deem percutaneous coronary intervention (PCI) of a non-infarct related artery (n-IRA) at the time of primary PCI (pPCI). This approach is being challenged by recent studies, which show benefits of complete rather than culprit vessel-only revascularization at the time of pPCI. However, these studies assessed grade of stenosis in the n-IRA by visual estimate. The impact of fractionalflow reserve (FFR) measurements during n-IRA PCI has not been assessed. Methods: COMPARE ACUTE is an ongoing prospective, randomized trial carried out at 14 sites across Europe and Asia. Patients were randomly allocated (2:1) to receive either FFR guided multi-vessel (MV) PCI vs. culprit vessel-only PCI in the setting of STEMI. The primary study endpoint is MACCE defined as death, myocardial infarction, any revascularization, or cerebral accident at 12 months. FFR measurements were done at the discretion of the operator directly after completion of pPCI in all n-IRA with visual estimate of !50% stenosis. Positive FFR measurement was defined as 0.80 under maximal hyperemia. Here we report analysis of the preliminary FFR data. Results: Since July 2011, 408 patients (613 FFR measurements) undergoing primary PCI with multi-vessel disease were enrolled. Mean age was 60.8 AE 13.2 (78.6% male) with Killip class I at presentation in 96%. In 35.6% the pPCI was performed in the LAD, 45.7% in the RCA and 18.6% in the RCX. Successful pPCI defined as TIMI 3 flow was achieved in 95.3%. FFR-measurements of n-IRA were performed in the LAD in 40.2%, RCA 26.8% and RCX 33.0%. In 56.5% the FFR measurement of a n-IRA was negative and in 43.5% positive.
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FFR-guided complete revascularization during primary PCI: Preliminary data from the COMPARE ACUTE trial University of ROSTOCK, Rostock, Germany Background: Current guidelines deem percutaneous coronary intervention (PCI) of a non-infarct related artery (n-IRA) at the time of primary PCI (pPCI). This approach is being challenged by recent studies, which show benefits of complete rather than culprit vessel-only revascularization at the time of pPCI. However, these studies assessed grade of stenosis in the n-IRA by visual estimate. The impact of fractionalflow reserve (FFR) measurements during n-IRA PCI has not been assessed. Methods: COMPARE ACUTE is an ongoing prospective, randomized trial carried out at 14 sites across Europe and Asia. Patients were randomly allocated (2:1) to receive either FFR guided multi-vessel (MV) PCI vs. culprit vessel-only PCI in the setting of STEMI. The primary study endpoint is MACCE defined as death, myocardial infarction, any revascularization, or cerebral accident at 12 months. FFR measurements were done at the discretion of the operator directly after completion of pPCI in all n-IRA with visual estimate of !50% stenosis. Positive FFR measurement was defined as 0.80 under maximal hyperemia. Here we report analysis of the preliminary FFR data. Results: Since July 2011, 408 patients (613 FFR measurements) undergoing primary PCI with multi-vessel disease were enrolled. Mean age was 60.8 AE 13.2 (78.6% male) with Killip class I at presentation in 96%. In 35.6% the pPCI was performed in the LAD, 45.7% in the RCA and 18.6% in the RCX. Successful pPCI defined as TIMI 3 flow was achieved in 95.3%. FFR-measurements of n-IRA were performed in the LAD in 40.2%, RCA 26.8% and RCX 33.0%. In 56.5% the FFR measurement of a n-IRA was negative and in 43.5% positive.
Conclusions: This preliminary data from the COMPARE ACUTE trial indicates the high portion of negative FFR-measurements in lesions found in non-infarct related arteries and visual estimated stenosis of >50%. This aspect should be paid regard to in the debate on multi-vessel primary PCI in STEMI. Background: iFR is a new, non-hyperemic, physiologic pressure index proposed for the assessment of intermediate coronary lesions. Recently, it has been suggested the value of a combined approach using iFR and FFR with intravenous adenosine (FFRiv) for the classification of coronary lesions located within the "grey zone" of physiologic severity. The intracoronary use of adenosine at high dose (FFRic) in combination with iFR might facilitate the widespread clinical use of these physiologic studies, as FFRic remains a simpler and less invasive technique that is associated with less side effects. The objective of this study was to determine the diagnostic accuracy of a systematic combined use of iFR and FFRic versus the classical FFRiv -used as the gold standardfor the assessment of intermediate coronary lesions. Methods: 38 consecutive patients with 44 intermediate coronary lesions (30-80% by QCA) were included in the study during a 6 month-period. iFR, FFRic (600 mg ic adenosine) and FFRiv (200 mg/kg/min) were systematically determined in all patients.
TCT-329
The diagnostic accuracy of the 2 tests were calculated against the reference standard of FFRiv using a cut-off diagnostic threshold set at 0.80. The area under the curve of each test was also analyzed. Results: 44 lesions were included. The mean age of patients was 66AE11, 81% were male and 29% were diabetics. The most frequent indication was stable angina (56%) and the more frequent vessel was left anterior descending coronary artery (47%) and most lesions were located at mid coronary segments (51%). The average angiographic severity was 51%AE 9 and the mean FFRiv was 0.81 AE 0.09. iFR ( optimal cut-off value found:0,89)sensitivity (100%) was higher than FFRic (89%). However, the specificity of iFR (70%) was less than that of FFRic (96%). Using a sequential approach (initial determination of iFR and then FFRic for cases positive according to iFR) an AUC of 0.98 (0.92-1) was obtained. Conclusions: Our findings suggest that iFR as a high sensitivity whereas FFRic has a high specificity, as compared with FFRiv. The sequential combined use of both tests appears to be very simple, provides a very high diagnostic yield.
